These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24130324)

  • 1. Reply from Lasse Gliemann, Jakob Schmidt, Jesper Olesen, Rasmus Sjørup Biensø, Sebastian Louis Peronard, Simon Udsen Grandjean, Stefan Peter Mortensen, Michael Nyberg, Jens Bangsbo, Henriette Pilegaard and Ylva Hellsten.
    Gliemann L; Schmidt J; Olesen J; Biensø RS; Peronard SL; Grandjean SU; Mortensen SP; Nyberg M; Bangsbo J; Pilegaard H; Hellsten Y
    J Physiol; 2013 Oct; 591(20):5253. PubMed ID: 24130324
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply fromLasse Gliemann, Jesper Olesen, Rasmus Sjorup Bienso, Stefan Peter Mortensen, Michael Nyberg, Jens Bangsbo, Henriette Pilegaard and Ylva Hellsten.
    Gliemann L; Olesen J; Biensø RS; Mortensen SP; Nyberg M; Schmidt JF; Bangsbo J; Pilegaard H; Hellsten Y
    J Physiol; 2014 Feb; 592(3):553. PubMed ID: 24488075
    [No Abstract]   [Full Text] [Related]  

  • 3. Food for thought--resveratrol vs. exercise training.
    Joyner MJ
    J Physiol; 2013 Oct; 591(20):4953. PubMed ID: 24130318
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans.
    Smoliga JM; Blanchard OL
    J Physiol; 2013 Oct; 591(20):5251-2. PubMed ID: 24130323
    [No Abstract]   [Full Text] [Related]  

  • 5. Resveratrol as a supplement to exercise training: friend or foe?
    Buford TW; Anton SD
    J Physiol; 2014 Feb; 592(3):551-2. PubMed ID: 24488074
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of resveratrol.
    Bukarica LG; Protić D; Kanjuh V; Heinle H; Novakoviĉ R; Sćepanović R
    Vojnosanit Pregl; 2013 Dec; 70(12):1145-50. PubMed ID: 24450260
    [No Abstract]   [Full Text] [Related]  

  • 7. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men.
    Gliemann L; Schmidt JF; Olesen J; Biensø RS; Peronard SL; Grandjean SU; Mortensen SP; Nyberg M; Bangsbo J; Pilegaard H; Hellsten Y
    J Physiol; 2013 Oct; 591(20):5047-59. PubMed ID: 23878368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated effects of exercise with an antioxidant supplement: too much of a good thing?
    Hartmann SE; Forbes SC
    J Physiol; 2014 Jan; 592(2):255-6. PubMed ID: 24453350
    [No Abstract]   [Full Text] [Related]  

  • 9. Supplementing exercise: translational considerations for nutraceutical and lifestyle interventions.
    Santos-Parker JR; Kaplon RE
    J Physiol; 2014 Feb; 592(3):427-8. PubMed ID: 24488072
    [No Abstract]   [Full Text] [Related]  

  • 10. Resveratrol for a longer life--if you're a yeast. The cardiovascular promise of this red wine compound has not been confirmed in humans.
    Harv Heart Lett; 2010 Nov; 21(3):4. PubMed ID: 21162174
    [No Abstract]   [Full Text] [Related]  

  • 11. Antioxidant effects of resveratrol in the cardiovascular system.
    Xia N; Daiber A; Förstermann U; Li H
    Br J Pharmacol; 2017 Jun; 174(12):1633-1646. PubMed ID: 27058985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of exercise training and resveratrol on vascular health in aging.
    Gliemann L; Nyberg M; Hellsten Y
    Free Radic Biol Med; 2016 Sep; 98():165-176. PubMed ID: 27085843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol in cardiovascular health and disease.
    Petrovski G; Gurusamy N; Das DK
    Ann N Y Acad Sci; 2011 Jan; 1215():22-33. PubMed ID: 21261638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on 'resveratrol commonly displays hormesis: occurrence and biomedical significance' by Calabrese et al.
    Das DK
    Hum Exp Toxicol; 2010 Dec; 29(12):1016-7. PubMed ID: 21115560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resveratrol in Pharmaceutical Chemistry].
    Orgován G; Noszál B
    Acta Pharm Hung; 2015; 85(4):123-9. PubMed ID: 26964400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects.
    Ashby J; Tinwell H; Pennie W; Brooks AN; Lefevre PA; Beresford N; Sumpter JP
    J Appl Toxicol; 1999; 19(1):39-45. PubMed ID: 9989476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol and grape juice differentially ameliorate cardiovascular autonomic modulation in L-NAME-treated rats.
    Dillenburg DR; Mostarda C; Moraes-Silva IC; Ferreira D; Bós Dda S; Duarte AA; Irigoyen MC; Rigatto K
    Auton Neurosci; 2013 Dec; 179(1-2):9-13. PubMed ID: 23810687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
    Thandapilly SJ; Louis XL; Behbahani J; Movahed A; Yu L; Fandrich R; Zhang S; Kardami E; Anderson HD; Netticadan T
    Hypertens Res; 2013 Oct; 36(10):866-72. PubMed ID: 23784505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential.
    Kroon PA; Iyer A; Chunduri P; Chan V; Brown L
    Curr Med Chem; 2010; 17(23):2442-55. PubMed ID: 20491649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol and polydatin as modulators of Ca
    Liu W; Chen P; Deng J; Lv J; Liu J
    Ann N Y Acad Sci; 2017 Sep; 1403(1):82-91. PubMed ID: 28665033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.